An evaluation of medical management for secondary prevention of ischaemic stroke in a tertiary stroke centre

Abstract Background Recurrent ischaemic strokes occur in 9-15% of patients within one year, the majority occurring within the first ninety days and up to 25% of patients who recover from a stroke are likely to have another stroke event within five years. Prompt introduction and optimisation of pharmacological therapy is essential for reducing recurrence. The mainstay of secondary prevention includes antiplatelet agents or anticoagulants, lipid lowering therapy and medications to optimise blood pressure and diabetes control. The primary aim of this study was to evaluate the current adherence to secondary prevention strategies in a tertiary stroke centre with a secondary aim of assessing achievement of target recommendations for LDL-C, HbA1c and blood pressure. Methods A retrospective chart review was conducted in a tertiary stroke centre. Patients were included if they were aged over 18 years and presenting to an outpatient stroke clinic with a diagnosis of an ischaemic stroke. Results A total of 49 patients were reviewed with 40 meeting our inclusion criteria. The median age was 69 years (range 42-90years) and 70% (n=28) were male. Four patients (10%) had a documented history of more than one ischaemic stroke. All patients were appropriately prescribed an anti-thrombotic agent and a cholesterol-lowering medication. 40% (n=16) of patients had LDL-C results above target (<1.8mmol/L; median 2; range 0.6-6.4). 30% (n=12) patients had a documented history of diabetes mellitus with a median HbA1c level of 42mmol/mol (range 28-87mmol/mol). No patient had a documented 24 hour blood pressure monitor result. Conclusion A significant number of patients attending their first follow-up appointment post stroke had inadequate lipid and diabetic control. Regular monitoring and target-driven therapy allow for regular optimisation of secondary prevention therapy which is crucial for improving clinical outcomes preventing recurrence.

Authors

Institutions

Publication Details

Journal
Age and Ageing
Published
2025-12-01
DOI
https://doi.org/10.1093/ageing/afaf318.125
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An evaluation of medical management for secondary prevention of ischaemic stroke in a tertiary stroke centre

Rory Durcan, David A. Williams, Anne-Marie Liddy, Karl Boyle et al.
Age and Ageing
Acute Ischemic Stroke Management
article

An evaluation of medical management for secondary prevention of ischaemic stroke in a tertiary stroke centre

Rory Durcan, David A. Williams, Anne-Marie Liddy, Karl Boyle, Nicole Cosgrave, Vanessa Farnan, Basmah Karembaks
article en

Abstract

Abstract Background Recurrent ischaemic strokes occur in 9-15% of patients within one year, the majority occurring within the first ninety days and up to 25% of patients who recover from a stroke are likely to have another stroke event within five years. Prompt introduction and optimisation of pharmacological therapy is essential for reducing recurrence. The mainstay of secondary prevention includes antiplatelet agents or anticoagulants, lipid lowering therapy and medications to optimise blood pressure and diabetes control. The primary aim of this study was to evaluate the current adherence to secondary prevention strategies in a tertiary stroke centre with a secondary aim of assessing achievement of target recommendations for LDL-C, HbA1c and blood pressure. Methods A retrospective chart review was conducted in a tertiary stroke centre. Patients were included if they were aged over 18 years and presenting to an outpatient stroke clinic with a diagnosis of an ischaemic stroke. Results A total of 49 patients were reviewed with 40 meeting our inclusion criteria. The median age was 69 years (range 42-90years) and 70% (n=28) were male. Four patients (10%) had a documented history of more than one ischaemic stroke. All patients were appropriately prescribed an anti-thrombotic agent and a cholesterol-lowering medication. 40% (n=16) of patients had LDL-C results above target (<1.8mmol/L; median 2; range 0.6-6.4). 30% (n=12) patients had a documented history of diabetes mellitus with a median HbA1c level of 42mmol/mol (range 28-87mmol/mol). No patient had a documented 24 hour blood pressure monitor result. Conclusion A significant number of patients attending their first follow-up appointment post stroke had inadequate lipid and diabetic control. Regular monitoring and target-driven therapy allow for regular optimisation of secondary prevention therapy which is crucial for improving clinical outcomes preventing recurrence.

Age and AgeingVol. 54(Supplement_4)
University of Medicine and Health Sciences (KN), Beaumont Hospital (IE)
Openalex Percentile: Top 50%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.